An observational study in Alveolar Bone Loss, sponsored by International Piezosurgery Academy. Active, not recruiting at 1 site in Italy. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-31.
Sponsored by International Piezosurgery Academy · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 14 studies in Alveolar Bone Loss by International Piezosurgery Academy — none open to participants now, 2 under way, none of them phase 3. Alveolar Bone Loss · International Piezosurgery Academy.
Among the 14 studies in Alveolar Bone Loss by International Piezosurgery Academy, this one is one of 3 that started in 2024, is one of 7 observational ones, and was the 12th registered.
319 studies on the registry are indexed under Alveolar Bone Loss; 79 are open to participants now.
Browse Alveolar Bone Loss studies →None of the 14 studies in Alveolar Bone Loss by International Piezosurgery Academy is open now. The open studies under Alveolar Bone Loss, anywhere →
Of the 47 Alveolar Bone Loss studies recruiting now, 19 (40%) set no upper age limit and 22 (47%) stop at 75 or younger; 4 take children under 18; 24 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
14 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 3 started in 2024.
This study's enrollment of 60 is above the median of 51 across 46 observational studies indexed under Alveolar Bone Loss.
Median enrollment 44 across the 7 interventional studies, 50 across the 7 observational. Of the 11 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
International Piezosurgery Academy is the lead sponsor of 24 studies on the registry; 3 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 14 studies in Alveolar Bone Loss by International Piezosurgery Academy, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Post-extractive alveolar ridge remodeling represents a physiological phenomenon that may hamper successive implant insertion. Several techniques have been proposed without any significant difference of efficacy among them. Moreover several research protocols of analysis have been proposed, including histomorphometric, radiological, clinical analysis.
The purpose of the present study is to test different alveolar ridge preservation techniques using histomorphometric and optical scanning analysis.
Primary objective The primary objective of the study is to clinically compare the effect on the preservation of the alveolar ridge using different techniques (dental roots in association with platelet rich fibrin, BARP (Biologically-oriented Alveolar Ridge Preservation), Ice Cream Cone Technique and unassisted socket healing).
Secondary objective The secondary objective is the collection of histological and histomorphometric data that allow to evaluate the quality and quantity of newly formed bone.
Study design Multicenter observational study of a prospective non-profit case-control.
List of centers involved in addition to our facility:
- University of Porto, Faculty of Dentistry, Specialization in Periodontology and Implantology.
Study population The study will be conducted in an outpatient hospital setting.
Number of patients to be enrolled to compare autogenous tooth roots (TR) and ice cream cone technique (ICCT): 32 patients among all the centers involved, of which 16 patients in the University of Porto and 16 patients in University of Trieste center including dropouts.
Number of patients to be enrolled to compare BARP and unassisted socket healing: 30 patients in the University of Trieste including dropouts.
Enrollment procedure All patients who meet the inclusion and exclusion criteria will be enrolled in the study following the administration of the Information Sheet and the acquisition of informed consent.
The choice of the alveolar ridge preservation protocol will be motivated by the clinicians experience and the patients preference among those currently validated (ice-cream cone technique, tooth root, etc.).
Autogenous tooth roots: under local anesthesia, a trapezoidal mucoperiosteal flap, extended to adjacent teeth mesially and distally, will be raised to expose the defect and remove granulation tissue. The dental root graft will be obtained by sectioning the extracted tooth at the cementoenamel junction and then separating the root longitudinally to fully expose the pulp chamber using a tungsten carbide bur with irrigation. The specimen will then be thoroughly cleaned using manual curettes on the external surface, while the removal of residual pulp tissue and/or root canal filling material will be performed using a tungsten carbide bur with irrigation. The tooth root specimen will be resized to fit the height and width of the post-extraction site to be regenerated and fixed using one to two titanium osteosynthesis screws. A blood sample will then be collected in two sterile glass-lined plastic tubes and processed to produce a platelet rich fibrin membrane. The blood sample will be centrifuged (2700 rpm for 12 minutes). The platelet rich fibrin will then be removed from the tubes and placed on the surgical site. Periosteal releasing incisions will be made to advance the mucoperiosteal flap, which will be repositioned coronally and secured with horizontal mattress sutures and single stitches to ensure a submerged healing condition.
Ice Cream Cone technique: under local anesthesia, the compromised tooth will be extracted atraumatically without raising a flap. A resorbable collagen membrane will be shaped into a cone and inserted into the socket, into which the xenograft will be placed; mattress sutures will then be placed.
BARP: under local anesthesia, the compromised tooth will be extracted atraumatically without raising a flap. After granulation tissue removal, the socket will be filled with a collagen sponge (deep collagen layer) up to 4 to 5 mm from the most coronal extensions of the buccal crest to create a support for the intra-alveolar graft. A bovine derived xenograft will be placed on top of the collagen sponge to fill the coronal part of the socket, avoiding overfilling (graft layer). Socket sealing will be performed with a new layer of collagen sponge that will be placed over the exposed portion of the graft layer and firmly held by sutures.
For all patients, after 26 weeks of healing, a mucoperiosteal flap will be raised to expose the target site and a titanium implant will be inserted. During this phase, using a core drill to prepare the implant site, it will also be functional to obtain a bone sample that will be subsequently analyzed.
Study Outcomes
The primary endpoint is the width of the alveolar ridge, which will be assessed in two stages:
The primary endpoint will be classified as follows. The secondary endpoints are represented by histomorphometric variables: newly formed mineralized tissue (New bone/Total volume), graft residues (RG/TV), newly formed non-mineralized tissue (Nonmineralised tissue/Total volume), total mineralized tissue that will be assessed at twenty-six weeks of healing (Mineralised tissue/total volume) evaluated as means and standard deviations and with χ2 test.
The primary endpoint will then be assessed in relation to complications and adverse events, such as:
The width of the alveolar ridge will be measured linearly and volumetrically, using digital scans processed by a 3D scanning software (Geomagic Control X, 3D System, Morrisville, USA) at the University of Trieste.
The data collected at follow-up and the outcome data are based on a clinical evaluation, considering the possible presence of complications and adverse events.
The histological and histomorphometric analysis of all samples will be performed by one of the authors, blinded to the study design and the origin of the biopsy. The biopsies, left inside the core drills to maintain the orientation of the bone core, will be rinsed with a cold 5% glucose solution to remove blood residues while maintaining the correct osmolarity (278 mOsm/L). The samples will then be fixed for 3 days in a 10% buffered formalin solution at pH 7.2 and then processed for histological and histomorphometric evaluation at the Bone Lab, University of Trieste. After this, the samples will be delivered to specialized and authorized companies for disposal, according to current legislation.
Collected data variables and sources
The following variables will be collected for each enrolled patient/participant:
Histological and histomorphometric analysis of all samples will be performed by one of the authors, blinded to the study design and biopsy origin. Biopsies, left inside the core drills to maintain the orientation of the bone core, will be rinsed with a cold 5% glucose solution to remove blood residues while maintaining the correct osmolarity (278 mOsm/L). Samples will then be fixed for 3 days in a 10% buffered formalin solution at pH 7.2 and then dehydrated in ascending series of alcohol rinses. After 5 days of preinfiltration in a 50% resin/alcohol solution, biopsies will be removed from the core drills and sample infiltration will be completed with methacrylate resin. After 12 days of polymerization, the samples will be cut along their longitudinal axis using a high-precision silicon carbide disc at 50 μm and then finished under running water with a series of polishing discs at approximately 30 ± 10 μm. They will then be mounted on slides and stained with acid fuchsin, toluidine blue and Von Kossa.
Following histological and histomorphometric analyses, the samples will be delivered to specialized and authorized companies for disposal, according to current legislation.
Statistical plan The statistical analysis will be performed by means of a computerized statistical package (SigmaStat 3.5, SPSS Inc., Germany). The data will be expressed as mean ± standard deviation and median (interquartile range), respectively, for parametric and non-parametric values.
Sample size calculation The aim of the study is to clinically compare different alveolar ridge preservation techniques.
Considering the outcomes of previously published studies, it was calculated that will be necessary to recruit 15 patients for each group to obtain a statistically significant result through a comparison between subpopulations with a statistical power of 95% and a significance of 0.05.
Patients needing for tooth extraction and possible implant insertion meeting inclusion and exclusion criteria were eligible
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Autoimmune disease
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HbA1c
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
collagen-bonegraft-collagen
Procedure: BARP
unassisted healing
Procedure: simple tooth extraction
tooth root and PRF
Procedure: tooth root and PRF
bonegraft and collagen membrane
deep layers of collagen, medium-superficial heterologous bone graft, superficial collagen layer
Also known as: Biologically-oriented Alveolar Ridge Preservation
tooth extraction without grafting procedure.
Autogenous roots derived from the extracted hopeless tooth and stabilized with osteosynthesis screws to reconstruct the missing buccal wall of the socket. The defect was then filled with PRF.
xenogeneic granules and a resorbable collagen membrane
alveolar volume
optical scanning comparison
Time frame: 6 months post-extractive
histomorphometric analysis
bone volume/total volume
Time frame: 6 months post-extraction
Plan to share: No
Ran from Jan 2024 to primary completion in Dec 2024, 11 months.
Of 22 observational studies under Alveolar Bone Loss, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 27. This study's 11 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
International Piezosurgery Academy